Creative Essences Inc.March 26, 2025

FDA 483 - Creative Essences Inc. - March 26, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Creative Essences Inc.

Record Details

Creative Essences Inc. in Santa Fe Springs, CA, a drug manufacturer, was cited with two observations during an FDA inspection. The inspection revealed deficiencies in equipment calibration and control, including overdue FTIR calibrations and uncalibrated stability chamber monitoring devices. Additionally, the R&D storage room used for holding OTC drug product stability samples was found to be unqualified.

Company: Creative Essences Inc.
Inspection Date: March 26, 2025
Product Type: Drugs
Office: Los Angeles District Office
People: Aranjeet Singh (FDA_PERSONNEL)
Jeffrey P. Raimondi (Consumer Safety Officer)

Open in Dashboard

ID · 44db524b-8a88-4f08-b109-dc63db59b5cb